U.S. appellate judges seem divided on gene editing patents decision

(Reuters) – U.S. appeals court judges appear divided over whether to allow a research center affiliated with MIT and Harvard to keep patents potentially worth billions of dollars on a groundbreaking gene editing technology known as CRISPR.

Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *